Citigroup’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,046
| Closed | -$9K | – | 6688 |
|
|
2022
Q2 | $9K | Buy |
8,046
+510
| +7% | +$533 | ﹤0.01% | 5432 |
|
|
2022
Q1 | $8K | Sell |
7,536
-18,102
| -71% | -$13.7K | ﹤0.01% | 5661 |
|
|
2021
Q4 | $18K | Buy |
25,638
+13,324
| +108% | +$10.8K | ﹤0.01% | 5424 |
|
|
2021
Q3 | $11K | Buy |
12,314
+6,979
| +131% | +$8.4K | ﹤0.01% | 5454 |
|
|
2021
Q2 | $9K | Buy |
5,335
+745
| +16% | +$1.25K | ﹤0.01% | 5723 |
|
|
2021
Q1 | $10K | Sell |
4,590
-7,275
| -61% | -$15.1K | ﹤0.01% | 5669 |
|
|
2020
Q4 | $15K | Buy |
11,865
+8,631
| +267% | +$10.3K | ﹤0.01% | 6811 |
|
|
2020
Q3 | $4K | Sell |
3,234
-4,875
| -60% | -$5.93K | ﹤0.01% | 7172 |
|
|
2020
Q2 | $9K | Sell |
8,109
-6,781
| -46% | -$6.27K | ﹤0.01% | 7115 |
|
|
2020
Q1 | $12K | Sell |
14,890
-1,662
| -10% | -$1.76K | ﹤0.01% | 6986 |
|
|
2019
Q4 | $17K | Buy |
16,552
+9,098
| +122% | +$11K | ﹤0.01% | 7008 |
|
|
2019
Q3 | $11K | Sell |
7,454
-7,010
| -48% | -$9.9K | ﹤0.01% | 7042 |
|
|
2019
Q2 | $21K | Sell |
14,464
-252
| -2% | -$390 | ﹤0.01% | 7070 |
|
|
2019
Q1 | $22K | Buy |
14,716
+383
| +3% | +$584 | ﹤0.01% | 6919 |
|
|
2018
Q4 | $21K | Sell |
14,333
-641
| -4% | -$982 | ﹤0.01% | 6865 |
|
|
2018
Q3 | $27K | Buy |
14,974
+4,196
| +39% | +$8.14K | ﹤0.01% | 6947 |
|
|
2018
Q2 | $20K | Buy |
+10,778
| New | +$20.1K | ﹤0.01% | 6927 |
|
|
2015
Q3 | – | Sell |
-368
| Closed | -$1K | – | 7863 |
|
|
2015
Q2 | $1K | Sell |
368
-1,142
| -76% | -$3.24K | ﹤0.01% | 7374 |
|
|
2015
Q1 | $6K | Sell |
1,510
-1,624
| -52% | -$6.01K | ﹤0.01% | 6673 |
|
|
2014
Q4 | $11K | Buy |
3,134
+2,550
| +437% | +$6.75K | ﹤0.01% | 6456 |
|
|
2014
Q3 | $1K | Buy |
584
+488
| +508% | +$3.26K | ﹤0.01% | 6962 |
|
|
2014
Q2 | $1K | Sell |
96
-746
| -89% | -$8.45K | ﹤0.01% | 6992 |
|
|
2014
Q1 | $12K | Sell |
842
-1,026
| -55% | -$16.1K | ﹤0.01% | 6272 |
|
|
2013
Q4 | $32K | Buy |
+1,868
| New | +$30.3K | ﹤0.01% | 5947 |
|
Citigroup's MBII Position: Q3 2022 in Review
Citigroup sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 8,046 shares — an estimated $9K sold.
Citigroup first reported a position in MBII in Q4 2013 and held it in 24 quarters. The position peaked at $32K in Q4 2013. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Citigroup reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Citigroup sold 8,046 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $9K.
- Citigroup first reported a position in Marrone Bio Innovations, Inc. in Q4 2013 and held it in 24 quarters.
- Citigroup's Marrone Bio Innovations, Inc. position peaked at $32K in Q4 2013.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.